Home / Inspections / 1187482

FDA Inspection 1187482 — Delaware Institute For Reproductive Medicine, P.A

Delaware Institute For Reproductive Medicine, P.A — FEI 3003939643

The FDA completed an inspection of Delaware Institute For Reproductive Medicine, P.A on Oct 26, 2022 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 26, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, DE (United States)

Facility

Other inspections at this facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.